The company has currently consolidated a network of collaborations with pharmaceutical and biotech companies as well as academic institutions, research centers and hospitals EU-wide. AROMICS is always looking for innovative, creative and value-driven alliances that allow us to create value for all stakeholders in the development of novel therapies and diagnostic products.

AROMICS provides its partners with:

• Innovative products: developing new drugs and diagnostic tools.
• Dynamic solutions: developing, implementing, and updating cutting-edge technologies and approaches.
• Expertise: a highly skilled, dedicated and experienced team.
• Multidisciplinarity: offering a broad range of relevant molecular and cell biology techniques.
• Specialization: applying functional genomics and proteomics in drug research and development.
• Flexibility: customer-oriented approach.
• State-of-the-art facilities.

AROMICS uses its various platforms to identify new targets and therapeutic leads as well as novel diagnostic markers focusing on cancer, neurodegenerative.

As a result, AROMICS pursues several partnership models:

• Co-development opportunities by establishing strategic alliances to evaluate new therapeutic and diagnostic products, technology platforms and services and sharing the IP generated.
• Collaboration opportunities through specific R&D&I projects.
• Services on a fee-for-project model, where the IP is owned by our clients.

For further information on collaborating with AROMICS, please contact info@aromics.es